Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PLA2G7 Kit ELISA

Lp-PLA2 Reactivité: Humain Colorimetric Sandwich ELISA 0.62 ng/mL - 40 ng/mL Plasma, Serum
N° du produit ABIN3164652
  • Antigène Voir toutes PLA2G7 (Lp-PLA2) Kits ELISA
    PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
    Reactivité
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Méthode de détection
    Colorimetric
    Type de méthode
    Sandwich ELISA
    Gamme de detection
    0.62 ng/mL - 40 ng/mL
    Seuil minimal de détection
    0.62 ng/mL
    Application
    ELISA
    Fonction
    The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of LpPLA2 in Serum,Plasma,Biological Fluids
    Type d'échantillon
    Plasma, Serum
    Analytical Method
    Quantitative
    Specificité

    This assay has high sensitivity and excellent specificity for detection of Phospholipase A2, Lipoprotein Associated (LpPLA2).
    No significant cross-reactivity or interference between Phospholipase A2, Lipoprotein Associated (LpPLA2) and analogues was observed.

    Réactivité croisée (Details)
    No significant cross-reactivity or interference between Phospholipase A2, Lipoprotein Associated (LpPLA2) and analogues was observed.
    Sensibilité
    0.255 ng/mL
    Ingrédients
    • Pre-coated, ready to use 96-well strip plate, flat buttom
    • Plate sealer for 96 wells
    • Reference Standard
    • Standard Diluent
    • Detection Reagent A
    • Detection Reagent B
    • Assay Diluent A
    • Assay Diluent B
    • Reagent Diluent (if Detection Reagent is lyophilized)
    • TMB Substrate
    • Stop Solution
    • Wash Buffer (30 x concentrate)
    • Instruction manual
    Featured
    Discover our best selling Lp-PLA2 Kit ELISA
    Top Product
    Discover our top product Lp-PLA2 Kit ELISA
  • Indications d'application
    • Limited by the current condition and scientific technology, we cannot completely conduct the comprehensive identification and analysis on the raw material provided by suppliers. So there might be some qualitative and technical risks to use the kit.
    • The final experimental results will be closely related to validity of the products, operation skills of the end users and the experimental environments. Please make sure that sufficient samples are available.
    • Kits from different batches may be a little different in detection range, sensitivity and color developing time.
    • Do not mix or substitute reagents from one kit lot to another. Use only the reagents supplied by manufacturer.
    • Protect all reagents from strong light during storage and incubation. All the bottle caps of reagents should be covered tightly to prevent the evaporation and contamination of microorganism.
    • There may be some foggy substance in the wells when the plate is opened at the first time. It will not have any effect on the final assay results. Do not remove microtiter plate from the storage bag until needed.
    • Wrong operations during the reagents preparation and loading, as well as incorrect parameter setting for the plate reader may lead to incorrect results. A microplate plate reader with a bandwidth of 10nm or less and an optical density range of 0-3 O.D. or greater at 450 ± 10nm wavelength is acceptable for use in absorbance measurement. Please read the instruction carefully and adjust the instrument prior to the experiment.
    • Even the same operator might get different results in two separate experiments. In order to get better reproducible results, the operation of every step in the assay should be controlled. Furthermore, a preliminary experiment before assay for each batch is recommended.
    • Each kit has been strictly passed Q.C test. However, results from end users might be inconsistent with our in-house data due to some unexpected transportation conditions or different lab equipments. Intra-assay variance among kits from different batches might arise from above factors, too.
    • Kits from different manufacturers for the same item might produce different results, since we have not compared our products with other manufacturers.
    Commentaires

    Information on standard material:
    The standard might be recombinant protein or natural protein, that will depend on the specific kit. Moreover, the expression system is E.coli or yeast or mammal cell. There is 0.05% proclin 300 in the standard as preservative.

    Information on reagents:
    The stop solution used in the kit is sulfuric acid with concentration of 1 mol/L. And the wash solution is TBS. The standard diluent contains 0.02 % sodium azide, assay diluent A and assay diluent B contain 0.01% sodium azide. Some kits can contain is BSA in them.

    Information on antibodies:
    The provided antibodies and their host vary in different kits.

    Volume d'échantillon
    100 μL
    Durée du test
    3 h
    Plaque
    Pre-coated
    Protocole
    The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Phospholipase A2, Lipoprotein Associated (LpPLA2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Phospholipase A2, Lipoprotein Associated (LpPLA2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Phospholipase A2, Lipoprotein Associated (LpPLA2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Phospholipase A2, Lipoprotein Associated (LpPLA2) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
    Préparation des réactifs
    1. Bring all kit components and samples to room temperature (18-25 °C) before use. If the kit will not be used up in one time, please only take out strips and reagents for present experiment, and leave the remaining strips and reagents in required condition.
    2. Standard - Reconstitute the Standard with 1.0 mL of Standard Diluent, keep for 10 minutes at room temperature, shake gently (not to foam). The concentration of the standard in the stock solution is 40 ng/mL. Prepare 7 tubes containing 0.5 mL Standard Diluent and produce a double dilution series. Mix each tube thoroughly before the next transfer. Set up 7 points of diluted standard such as 40 ng/mL, 20 ng/mL, 10 ng/mL, 5 ng/mL, 2.5 ng/mL, 1.25 ng/mL, 0.625 ng/mL, and the last microcentrifuge tube with Standard Diluent is the blank as 0 ng/mL.
    3. Detection Reagent A and Detection Reagent B - If lyophilized reconstitute the Detection Reagent A with 150μL of Reagent Diluent, keep for 10 minutes at room temperature, shake gently (not to foam). Briefly spin or centrifuge the stock Detection A and Detection B before use. Dilute them to the working concentration 100-fold with Assay Diluent A and B, respectively.
    4. Wash Solution - Dilute 20 mL of Wash Solution concentrate (30x) with 580 mL of deionized or distilled water to prepare 600 mL of Wash Solution (1x).
    5. TMB substrate - Aspirate the needed dosage of the solution with sterilized tips and do not dump the residual solution into the vial again.

    Note:

    1. Making serial dilution in the wells directly is not permitted.
    2. Prepare standards within 15 minutes before assay. Please do not dissolve the reagents at 37 °C directly.
    3. Please carefully reconstitute Standards or working Detection Reagent A and B according to the instruction, and avoid foaming and mix gently until the crystals are completely dissolved. To minimize imprecision caused by pipetting, use small volumes and ensure that pipettors are calibrated. It is recommended to suck more than 10μL for one pipetting.
    4. The reconstituted Standards, Detection Reagent A and Detection Reagent B can be used only once.
    5. If crystals have formed in the Wash Solution concentrate (30x), warm to room temperature and mix gently until the crystals are completely dissolved.
    6. Contaminated water or container for reagent preparation will influence the detection result.
    Précision du teste

    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Phospholipase A2, Lipoprotein Associated (LpPLA2) were tested 20 times on one plate, respectively.
    Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Phospholipase A2, Lipoprotein Associated (LpPLA2) were tested on 3 different plates, 8 replicates in each plate.
    CV(%) = SD/meanX100
    Intra-Assay: CV<10%
    Inter-Assay: CV<12%

    Restrictions
    For Research Use only
  • Précaution d'utilisation
    The Stop Solution suggested for use with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.
    Conseil sur la manipulation
    The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5 % within the expiration date under appropriate storage condition.
    To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
    Stock
    4 °C
    Stockage commentaire
    • For unopened kit: All the reagents should be kept according to the labels on vials. The Standard, Detection Reagent A, Detection Reagent B and the 96-well strip plate should be stored at -20°C upon receipt while the others should be at 4°C.
    • For opened kit: When the kit is opened, the remaining reagents still need to be stored according to the above storage condition. Besides, please return the unused wells to the foil pouch containing the desiccant pack, and reseal along entire edge of zip-seal.
      Note: It is highly recommended to use the remaining reagents within 1 month provided this is within the expiration date of the kit.
    • For ELISA kit, 1 day storage at 37°C can be considered as 2 months at 4°C, which means 3 days at 37°C equaling 6 months at 4°C.
    Date de péremption
    6 months
  • Tsai, Wu, Tseng, Leu, Yin, Lin, Chang, Wang, Yeh, Wu, Chen: "Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions." dans: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 120, Issue 1 Pt 3, pp. 728-736, (2021) (PubMed).

    El Messaoudi, Wouters, van Swieten, Pickkers, Noyez, Kievit, Abbink, Rasing-Hoogveld, Bouw, Peters, Coenen, Donders, Riksen, Rongen: "Effect of dipyridamole on myocardial reperfusion injury: A double-blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery." dans: Clinical pharmacology and therapeutics, Vol. 99, Issue 4, pp. 381-9, (2016) (PubMed).

    Shabalina, Liapina, Rochev, Kostyreva, Tanashian, Suslina: "[In vitro lipid-lowering and fibrinolytic effects of regulatory leucine-containing glyprolines in human blood]." dans: Izvestiia Akademii nauk. Seriia biologicheskaia / Rossi?skaia akademiia nauk, Issue 1, pp. 85-9, (2015) (PubMed).

    Yadav, Liu, Kwok, Hama, France, Eatough, Pemberton, Schofield, Siahmansur, Malik, Ammori, Issa, Younis, Donn, Stevens, Durrington, Soran: "Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients." dans: Journal of the American Heart Association, Vol. 4, Issue 9, pp. e001508, (2015) (PubMed).

    Fortunato, Bláha, Bis, Štásek, Andrýs, Vojá?ek, Jurašková, Sobotka, Polanský, Brtko: "Lipoprotein-associated phospholipase A? mass level is increased in elderly subjects with type 2 diabetes mellitus." dans: Journal of diabetes research, Vol. 2014, pp. 278063, (2014) (PubMed).

    Mai, Wang, Wen, Lin, Niu: "Lipoprotein-associated phospholipase A2 and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus." dans: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, Vol. 30, Issue 3, pp. 241-4, (2014) (PubMed).

    Tremblay, Lamarche, Deacon, Weisnagel, Couture: "Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes." dans: Metabolism: clinical and experimental, Vol. 63, Issue 9, pp. 1141-8, (2014) (PubMed).

    Gouni-Berthold, Berthold, Huh, Berman, Spenrath, Krone, Mantzoros: "Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo." dans: PLoS ONE, Vol. 8, Issue 9, pp. e72858, (2013) (PubMed).

    Rosing, Fobker, Kannenberg, Gunia, DellAquila, Kwiecien, Stypmann, Nofer: "Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients." dans: Atherosclerosis, Vol. 230, Issue 1, pp. 164-70, (2013) (PubMed).

    Enseleit, Sudano, Périat, Winnik, Wolfrum, Flammer, Fröhlich, Kaiser, Hirt, Haile, Krasniqi, Matter, Uhlenhut, Högger, Neidhart, Lüscher, Ruschitzka, Noll: "Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study." dans: European heart journal, Vol. 33, Issue 13, pp. 1589-97, (2012) (PubMed).

    Colak, Senates, Ozturk, Doganay, Coskunpinar, Oltulu, Eren, Sahin, Ozkanli, Enc, Ulasoglu, Tuncer: "Association of serum lipoprotein-associated phospholipase A2 level with nonalcoholic fatty liver disease." dans: Metabolic syndrome and related disorders, Vol. 10, Issue 2, pp. 103-9, (2012) (PubMed).

    Schaefer, McNamara, Asztalos, Tayler, Daly, Gleason, Seman, Ferrari, Rubenstein: "Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects." dans: The American journal of cardiology, Vol. 95, Issue 9, pp. 1025-32, (2005) (PubMed).

    Savoiardo: "The vascular territories of the carotid and vertebrobasilar systems. Diagrams based on CT studies of infarcts." dans: Italian journal of neurological sciences, Vol. 7, Issue 4, pp. 405-9, (1986) (PubMed).

  • Antigène Voir toutes PLA2G7 (Lp-PLA2) Kits ELISA
    PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
    Autre désignation
    LpPLA2 (Lp-PLA2 Produits)
    Synonymes
    LDL-PLA2 Kit ELISA, LP-PLA2 Kit ELISA, PAFAD Kit ELISA, PAFAH Kit ELISA, Lp-PLA2 Kit ELISA, PAF-AH Kit ELISA, R75400 Kit ELISA, zgc:77563 Kit ELISA, phospholipase A2 group VII Kit ELISA, phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) Kit ELISA, PLA2G7 Kit ELISA, Pla2g7 Kit ELISA, pla2g7 Kit ELISA
    UniProt
    Q13093
    Pathways
    Peptide Hormone Metabolism
Vous êtes ici:
Support technique